MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$102,198K
Income tax provision
-$67K
Loss before income
taxes
-$102,265K
License And Other
$3,123K
Product
$30,886K
Total other (expense)
income, net
-$84,421K
Loss from operations
-$17,844K
Interest income
$607K
Revenue from contract
with customer,...
$34,079K
Other income
(expense), net
-$10,044K
(loss) gain on
extinguishment of debt
-$31,182K
Interest expense
$12,619K
something is missing
-$31,182.5K
Total operating
expenses
$51,923K
Selling, general and
administrative
$22,772K
Research and development
$27,667K
Cost of
sales-Product
$1,393K
Back
Back
Income Statement
source: myfinsight.com
Karyopharm Therapeutics Inc. (KPTI)
Karyopharm Therapeutics Inc. (KPTI)